Literature DB >> 33716481

A Stepwise Approach for Preventing Suicide by Lethal Poisoning.

Jasmine E Carpenter1, Tiffany Lee1, Elizabeth Greene1, Eileen Holovac1.   

Abstract

BACKGROUND: Suicide is a global phenomenon and is the 10th leading cause of death in the US. Veterans are more likely to die by suicide than those in the general population. In 2018, the suicide rate for all US veterans was 1.5 times higher than the rate for nonveterans, after adjusting for population differences in age and sex. In light of this disparity, suicide prevention is one of the highest priorities for the US Department of Veterans Affairs (VA). One major goal of the VA suicide prevention strategy is to reduce access to lethal means. OBSERVATIONS: This article will provide information on medications with high lethality and a stepwise approach for how health care providers may limit lethal medications for patients at high risk for suicide. The first step is to determine suicide risk. More than 90% of those who die by suicide have a psychiatric diagnosis at the time of death. Clinicians can use risk assessment tools, such as the Veterans Health Administration Suicide Prevention Population Risk Identification and Tracking for Exigencies tool. The second step is to identify substances strongly associated with fatalities. According to the American Association of Poison Control Centers, the pharmaceutical classes associated with the largest number of fatalities are stimulants and street drugs, followed by analgesics, cardiovascular agents, antidepressants, antipsychotics, and sedatives/hypnotics. The third step is to consider potential drug-drug interactions, such as the combination of opioids and sedative-hypnotics. Finally, clinicians need to address risks. With high-risk patients it may be preferential to prescribe medications that are less lethal. All patients with a high risk of suicide should receive lethal means counseling.
CONCLUSIONS: While firearms continue to be the most lethal means for veteran suicide, intentional poisoning with medications or substances also is a common method for suicide, especially for female veterans. Having knowledge of medications with high lethality and limiting access to these agents can be a successful strategy for reducing suicide deaths.
Copyright © 2021 Frontline Medical Communications Inc., Parsippany, NJ, USA.

Entities:  

Year:  2021        PMID: 33716481      PMCID: PMC7953861          DOI: 10.12788/fp.0087

Source DB:  PubMed          Journal:  Fed Pract        ISSN: 1078-4497


  21 in total

1.  Development and applications of the Veterans Health Administration's Stratification Tool for Opioid Risk Mitigation (STORM) to improve opioid safety and prevent overdose and suicide.

Authors:  Elizabeth M Oliva; Thomas Bowe; Sara Tavakoli; Susana Martins; Eleanor T Lewis; Meenah Paik; Ilse Wiechers; Patricia Henderson; Michael Harvey; Tigran Avoundjian; Amanuel Medhanie; Jodie A Trafton
Journal:  Psychol Serv       Date:  2017-02

2.  Electronic Medical Record Alert Associated With Reduced Opioid and Benzodiazepine Coprescribing in High-risk Veteran Patients.

Authors:  Carol A Malte; Douglas Berger; Andrew J Saxon; Hildi J Hagedorn; Carol E Achtmeyer; Anthony J Mariano; Eric J Hawkins
Journal:  Med Care       Date:  2018-02       Impact factor: 2.983

3.  Suicide acts in 8 states: incidence and case fatality rates by demographics and method.

Authors:  R S Spicer; T R Miller
Journal:  Am J Public Health       Date:  2000-12       Impact factor: 9.308

Review 4.  Pharmacology, pathophysiology and management of calcium channel blocker and beta-blocker toxicity.

Authors:  Christopher R DeWitt; Javier C Waksman
Journal:  Toxicol Rev       Date:  2004

5.  Suicide risk assessment: a review of risk factors for suicide in 100 patients who made severe suicide attempts. Evaluation of suicide risk in a time of managed care.

Authors:  R C Hall; D E Platt; R C Hall
Journal:  Psychosomatics       Date:  1999 Jan-Feb       Impact factor: 2.386

Review 6.  Abuse of fentanyl: An emerging problem to face.

Authors:  Katarzyna Kuczyńska; Piotr Grzonkowski; Łukasz Kacprzak; Jolanta B Zawilska
Journal:  Forensic Sci Int       Date:  2018-06-02       Impact factor: 2.395

7.  Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).

Authors:  Herbert Y Meltzer; Larry Alphs; Alan I Green; A Carlo Altamura; Ravi Anand; Alberto Bertoldi; Marc Bourgeois; Guy Chouinard; M Zahur Islam; John Kane; Ranga Krishnan; J P Lindenmayer; Steven Potkin
Journal:  Arch Gen Psychiatry       Date:  2003-01

8.  Suicide Case-Fatality Rates in the United States, 2007 to 2014: A Nationwide Population-Based Study.

Authors:  Andrew Conner; Deborah Azrael; Matthew Miller
Journal:  Ann Intern Med       Date:  2019-12-03       Impact factor: 25.391

9.  2018 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 36th Annual Report.

Authors:  David D Gummin; James B Mowry; Daniel A Spyker; Daniel E Brooks; Michael C Beuhler; Laura J Rivers; Heba A Hashem; Mark L Ryan
Journal:  Clin Toxicol (Phila)       Date:  2019-11-21       Impact factor: 4.467

10.  Risk Assessment Tools and Data-Driven Approaches for Predicting and Preventing Suicidal Behavior.

Authors:  Sumithra Velupillai; Gergö Hadlaczky; Enrique Baca-Garcia; Genevieve M Gorrell; Nomi Werbeloff; Dong Nguyen; Rashmi Patel; Daniel Leightley; Johnny Downs; Matthew Hotopf; Rina Dutta
Journal:  Front Psychiatry       Date:  2019-02-13       Impact factor: 4.157

View more
  1 in total

1.  Alprazolam-related deaths in Scotland, 2004-2020.

Authors:  John Martin Corkery; Amira Guirguis; Stefania Chiappini; Giovanni Martinotti; Fabrizio Schifano
Journal:  J Psychopharmacol       Date:  2022-08-01       Impact factor: 4.562

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.